You searched Opinion and Media for "" and got 1164 results
If years of arguing about supermarkets and supermarket policy have taught us anything, it’s that allowing another supermarket chain to enter the New Zealand market is in the national interest. So why won’t the government tell the Overseas Investment Office? Read more
Collective nouns are fun. A murder of crows is great. Read more
Aucklanders have yet more rail disruption to look forward to this Christmas. Last week, in a bolt from the blue, KiwiRail and Auckland Transport announced a series of major shutdowns to train lines in the Super City. Read more
Economist Dave Heatley finds himself in something of a quandary. New Zealand’s economists firmly support the Emissions Trading Scheme as the best way of achieving New Zealand’s net zero target. Read more
Oliver Hartwich chats with ACT’s Transport and Climate Change spokesperson Simon Court about the Clean Car Scheme and how it's adding bureaucracy, not reducing emissions. To listen to our latest podcasts, please subscribe to The New Zealand Initiative podcast on iTunes, Spotify or The Podcast App. Read more
Chief Economist at The New Zealand Initiative Dr Eric Crampton is in the studio to talk economics. Tonight he's talking competition and antitrust laws. Read more
Hard times make for bad thinking. Inflation has been running at 7.3%, or at 7.8% if you remember how the petrol excise holiday works. Read more
Mike Hosking discusses Roger Partridge's NZ Herald column on protecting highly productive soils. Read more
The next incoming government will need to do its policy thinking beforehand if it is to tackle the current policy mess effectively. It will face serious problems in housing, health, education, social welfare, and environmental and planning laws, just to mention the biggest areas. Read more
In 2020, my report, Pharmac: The right prescription? for the New Zealand Initiative found much to compliment in Pharmac’s pursuit of its statutory duty to obtain the best reasonably achievable health outcomes for eligible people from pharmaceuticals within the subsidy budget. Read more